Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: In-vivo/in-vitro correlation and inducibility

Pharmacogenetics

Volumn 7, Issue 6, 1997, Pages 441-452

  Treluyer, Jean Marc ^a   Gueret, Gildas ^b   Cheron, Gérard ^a   Sonnier, Michelle ^b   Cresteil, Thierry ^b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

CYP2C; Diazepam; Human neonates; Induction

Indexed keywords

CYTOCHROME P450 ISOENZYME; DIAZEPAM; DRUG METABOLITE; OXAZEPAM; TEMAZEPAM; TOLBUTAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG HYDROXYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; FETUS; HUMAN; HUMAN TISSUE; INFANT; LIVER MICROSOME; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINARY EXCRETION;

EID: 0030699162     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199712000-00002     Document Type: Article

References (52)

1. Andersson T, Miners JO, Veronese ME, Birkett DJ. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3 A isoforms. Br J Clin Pharmacol 1994: 38, 131-137.
2. Bertilsson L, Henthorn TK, Sanz E, Tybring G, Sawe J, Villén T. Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin hydroxylation phenotype. Clin Pharmacol Ther 1989: 45, 348-355.
3. Brian WR, Srivastava PK, Umberhauer DR, Lloyd RS, Guengerich FP. Expression of a human liver cytochrome P450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry 1989: 28, 4993-4999.
4. Cresteil T, Flinois JP, Pfister A, Leroux JP. Effect of microsomal preparations and induction on cytochrome P450-dependent monooxygenases in fetal and neonatal rat liver. Biochem Pharmacol 1979: 28, 2057-2063.
5. Cresteil T, Beaune P, Kremers P, Flinois JP, Leroux JP. Drug-metabolizing enzymes in human foetal liver: partial resolution of multiple cytochromes P450. Ped Pharmacol 1982: 2, 199-207.
6. Cresteil T, Beaune P, Kremers P, Celier C, Guengerich FP Leroux JP. Immunoquantification of epoxide hydrolase and cytochrome P-450 isoenzymes in fetal and adult human liver microsomes. Eur J Biochem 1985: 151, 345-350.
7. Cresteil T, Jaiswal AK, Eisen HJ. Transcriptional control of human cytochrome PI-450 gene expression by 2,3,7,8 tetrachlorodibenzo-p-dioxin in human tissue culture cell lines. Arch Biochem Biophys 1987: 253, 233-240.
8. Cresteil T, Monsarrat B, Alvinerie P, Treluyer JM, Vieira I, Wright M. Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 1994: 54, 386-392.
9. De Morais SMF, Schweikl H, Blaisdell J, Goldstein JA. Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. Biochem Biophys Res Commun 1993: 194, 194-201.
10. Fujita S, Tatsuno J, Kitani K, Suzuki T. Age-associated alterations in diazepam metabolizing enzyme activities in male and female rats. Drug Metab Dispos 1990: 18, 812-814.
11. Furuya H, Meyer UA, Gelboin HV, Gonzalez FJ. Polymerase chain reaction-directed identification, cloning and quantification of human CYP2C18 mRNA. Mol Pharmacol 1991: 40, 375-382.
12. Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP. Characterization of cDNAs mRNAs and proteins related to human liver microsomal cytochrome P450 (S)-mephenytoin 4′-hydroxylase. Biochemistry 1988: 27, 6929-6940.
13. Goldstein JA, DeMorais SME. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 1994: 4, 285-299.
14. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. Evidence that CYP2C19 is the major S-mephenytoin 4′-hydroxylase in humans. Biochemistry 1994: 33, 1743-1752.
15. Greim H. Synthesestoigerung und abbauhemmung bei der vermchrung der mikrosomalen cytochrome P450 und b5 durch phenobarbital. Arch Pharmacol 1970: 266, 261-275.
16. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Maenpää J, Rane A, Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 1994: 48, 59-64.
17. Hamada H, Petrino MG, Kakunaga T. Molecular structure and evolutionary origin of human cardiac muscle actin gene. Proc Natl Acad Sci USA 1982: 79, 5901-5905.
18. Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T. Gene structure of CYP3A4 an adult-specific form of cytochrome P450 in human livers and its transcriptional control. Eur J Biochem 1993: 218, 585-595.
19. Ibeanu GC, Goldstein JA. Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 1995: 34, 8028-8036.
20. Jacqz-Aigrain E, Funck-Brentano C, Cresteil T. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. Pharmacogenetics 1993: 3, 197-204.
21. Knodell RG, Hall SD, Wilkinson GR, Guengerich FP. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P450 involved in methyl hydroxylation and relationship to in vivo disposition. J Pharmacol Exp Ther 1987: 241, 1112-1119.
22. Knodell RG, Dubey RK, Wilkinson GR, Guengerich FP. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation. J Pharmacol Exp Ther 1988: 245, 845-849.
23. Ladona MG, Spalding DJM, Ekman L, Lindström B, Rane A. Human fetal and adult liver metabolism of ethylmorphine. Relation to immunodetected cytochrome P450PCN and interactions with important fetal corticosteroids. Biochem Pharmacol 1989: 38, 3147-3155.
24. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. Expression of CYP3 A in the human liver: evidence that the shift between 3A7 and 3A4 occurs immediately after birth. Eur J Biochem 1997: 247, 625-634
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970: 227, 680-685.
26. Lemoine A, Marie S, Cresteil T. Expression of cytochrome P450 isozymes in the liver of hypophysectomized rats. Evidence for different regulation mechanisms concerning P450IIB and P450IIIC subfamilies. Eur J Biochem 1988: 177, 597-604.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951: 193, 265-275.
28. Maenpää J, Rane A, Raunio H, Honkakoski P, Pelkonen O. Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse. Biochem Pharmacol 1993: 45, 899-907.
29. Moroy T, Etiemble J, Trepo C, Thiollais P, Buendia MA. Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J 1985: 4, 1507-1514.
30. Morselli PL, Principi N, Tognoni G, Reali E, Belvedere G, Standen SM, Sereni F. Diazepam elimination in premature and full-term infants and children. J Perinat Med 1973: 1, 133-141.
31. Morselli PL. Psychotropic drugs. In: Morselli PL. ed. Drug disposition during development. New York: Spectrum Publications Inc. 1977: 431-474.
32. Nelson D, Koymans L, Kamataki T, Stegemans JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996: 6, 1-42.
33. Pelkonen O, Kaltiala EH, Larmi KI, Karki NT. Comparison of activities of drug-metabolizing enzymes in human fetal and adult livers. Clin Pharmacol Ther 1973: 14, 840-846.
34. Perrot N, Nalpas B, Yang CS, Beaune P. Modulation of cytochrome P450 isozymes in human liver by ethanol and drug intake. Eur J Clin Invest 1989: 19, 563-570.
35. Rahman A, Korzekwa KR, Grogan J, Gonzalez FJ, Harris JW. Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8. Cancer Res 1994: 54, 5543-5546.
36. Rake M, Roberts I, Gibson P, Baudouin S, Hall-Craggs M, Lodola A, Burnet F. Profiles of urinary diazepam metabolites in alcoholics with different extents of liver damage. IRCS Medical Sci 1985: 13, 146-147.
37. Rao SN, Dhar AK, Kutt H, Okamoto M. Determination of diazepam and its pharmacologically active metabolites in blood by bondelut column extraction and reverse-phase high performance liquid chromatography. J Chromatogr 1982: 231, 341- 348.
38. Ratanasavanh D, Beaune P, Morel F, Flinois JP, Guengerich FP, Guillouzo A. Intralobular distribution and quantitation of cytochrome P450 enzymes in human liver as a function of age. Hepatology 1991: 13, 1142-1151.
39. Relling MV, Aoyama T, Gonzalez FJ, Meyer UA. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J Pharmacol Exp Ther 1990: 252, 442-447.
40. Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 1991: 30, 3247-3255.
41. Sereni F, Mandelli M, Principi N, Tognoni G, Pardi G, Morselli PL. Induction of drug metabolizing enzyme activities in the human fetus and in the newborn infant. Enzyme 1973: 15, 318-329.
42. Shimada T, Misono KS, Guengerich FP. Human liver microsomal cytochrome P450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. J Clin Chem 1986: 261, 909-921.
43. Srivastava PK, Yun CH, Beaune P, Ged C, Guengerich FP. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4′-hydroxylase cytochrome P450 enzymes. Mol Pharmacol 1991: 40, 69-79.
44. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979: 76, 4350-4354.
45. Treluyer JM, Jacqz-Aigrain E, Alvarez F, Cresteil T. Expression of CYP2D6 in the developing human liver. Eur J Biochem 1991: 202, 583-588.
46. Treluyer JM, Cheron G, Sonnier M, Cresteil T. Cytochrome P450 expression in Sudden Infant Death Syndrome. Biochem Pharmacol 1996: 52, 497-504.
47. Umberhauer UA, Martin MV, Lloyd RS, Guengerich FP. Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P450 S-mephenytoin 4-hydroxylase. Biochemistry 1987: 26, 1094-1099.
48. Vieira I, Sonnier M, Cresteil T. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem 1996: 238, 476-483.
49. Wang PP, Beaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D, Guengerich FP. Purification and characterization of six cytochrome P450 isozymes from human liver microsomes. Biochemistry 1983: 22, 5375-5383.
50. Yaffe SJ, Rane A, Sjoqvist F, Boreus LO, Orrenius S. The presence of monooxygenase system in human fetal liver microsomes. Life Science 1970: 9, 1189-1200.
51. Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y, Kato R. Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 1993: 3, 291-301.
52. Yasumori T, Ouin-Hua L, Yamazoe Y, Ueda M, Tsuzuki T, Kato R. Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4′-hydroxylation. Pharmacogenetics 1994: 4, 323-331.